Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Ascent Solar Technologies Leadership Offers Thin-Film Solar Facility Tours to Prospective Customers During 40th Annual Space Symposium
-
Bombardier Announces April 3, 2025 as the Start of its New Normal Course Issuer Bid
-
Going To Great Lengths: Habit Burger & Grill Takes Extreme Measures to Deliver the #1 Double Char to First-Time Fans
-
The Board of Directors' resolution on the issuance of convertible loans
-
Nexxen Announces March 2025 Share Repurchase Program Summary
-
Interactive Entertainment Group Inc. Ranks No. 101 on the 2025 Inc. Regionals: Northeast List, Marking Its Third Appearance
-
Endeavour Silver Announces Expansion into Peru with Acquisition of Minera Kolpa, Copper Stream and Bought Deal Financing
-
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
-
Kraig Biocraft Laboratories Secures Four Registered Trademarks for SpydaSilk® Brand, to Advance Commercialization Strategy for Recombinant Spider Silk
-
Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
-
Itafos Confirms Declaration of Special Dividend
-
CPAB publishes 2024 annual report
-
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update
-
Cartesian Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
SynOx Therapeutics Announces Board Chair Transition to Align with Advancing Regulatory and Commercialization Strategy
-
Rio Silver Pivots to High-Grade Silver Exploration / Exploitation - Announces Executive Changes
-
Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists
-
Federal parties can protect jobs and affordability by permanently exempting all food from GST/HST, in face of new U.S. tariffs
-
AmpliTech Reports FY 2024 Financial Results
-
Limekiln Wind Farm, Scotland: Boralex’s First Production Site in the United Kingdom Now Operational
-
Ultralife Corporation Reports Fourth Quarter Results
-
Marimaca Commences Trading on the Australian Securities Exchange
-
Renasant Corporation Completes Merger with The First Bancshares, Inc.
-
Codexis Appoints Cynthia Collins to Board of Directors
-
Attralus Presents New Data on Its Pan-Amyloid Diagnostic Candidates at the 2025 American College of Cardiology (ACC) Annual Scientific Session
-
CGS Immersive Unveils 2025 Operational Excellence Outlook Report: Embracing Emerging Technology Critical to Future-Proofing Businesses
-
Medicenna to Present at Jones Healthcare and Technology Innovation Conference
-
Tovecimig (CTX-009) Meets Primary Endpoint in the Ongoing Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer
-
Lantronix Names Tech Industry Veteran Todd Rychecky General Manager and Head of Out-of-Band Management Business
-
Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition
-
Unicycive Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
-
Autolus Therapeutics to Host R&D Investor Event on Wednesday, April 23, 2025
-
Trust Stamp files its 2024 10-K and gives forward-looking revenue and expense guidance
-
Sonoco Completes Sale of Thermoformed and Flexibles Packaging Business to TOPPAN Holdings, Inc.
-
Purple Biotech to Participate in Panel Discussion at Canaccord Genuity Horizons in Oncology Virtual Conference on April 7, 2025
-
Axsome Therapeutics Announces Topline Results of PARADIGM Phase 3 Proof-of-Concept Trial of Solriamfetol in Major Depressive Disorder (MDD) with and without Excessive Daytime Sleepiness (EDS)
-
Aquestive Therapeutics Announces Positive Topline PK Results from its Pediatric Study and Completes the NDA Submission for Anaphylm™ (epinephrine) Sublingual Film
-
Bitfarms Provides March 2025 Production and Operations Update
-
Cielo Announces Relocation of First Planned Facility to British Columbia and Provides Update on Proposed Asset Acquisition and Corporate Matters
-
3D Systems Completes Sale of Geomagic Software Portfolio
-
Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation
-
Fengate consortium selected to deliver six new schools in Alberta, Canada
-
CECO Environmental Announces Completion of the Divestiture of Its Fluid Handling Business to May River Capital
-
Apellis Announces FDA Acceptance and Priority Review of the Supplemental New Drug Application for EMPAVELI® (pegcetacoplan) for C3G and Primary IC-MPGN
-
Autolus Therapeutics to Host R&D Investor Event on Wednesday, April 23, 2025
-
Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
-
Whitestone REIT Announces First Quarter 2025 Earnings Webcast and Conference Call
-
Combatting Cyber Threats with AI: Darktrace and Climb Channel Solutions Sign Distribution Agreement for North America
-
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
-
Results of the Offering of Bigbank AS AT1 Bonds
